Regeneron antibody saves lives in some hospitalized Covid patients, study finds

A monoclonal antibody treatment for Covid-19 developed by Regeneron saved lives among hospitalized patients who had not mounted their own immune response, a finding that could dramatically change the way that doctors will use the therapy, researchers in the United Kingdom announced Wednesday.